# Safety and Efficacy of the Effect of Isosorbide Mononitrate in Reducing Pain During Levonorgestrel-releasing Intrauterine Device Insertion

> **NCT04311658** · PHASE3 · UNKNOWN · sponsor: **Cairo University** · enrollment: 88 (estimated)

## Conditions studied

- Contraception

## Interventions

- **DRUG:** Isosorbide Mononitrate 40 MG
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04311658
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-03-30
- **Primary completion:** 2020-06-25
- **Final completion:** 2020-07-05
- **Target enrollment:** 88 (ESTIMATED)
- **Last updated:** 2020-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04311658

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04311658, "Safety and Efficacy of the Effect of Isosorbide Mononitrate in Reducing Pain During Levonorgestrel-releasing Intrauterine Device Insertion". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04311658. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*